Early diagnosis and discontinuation of the offending agent is critical in drug-induced lupus erythematosus

Author：

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.27, Iss.12, 2011-12, pp. : 19-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug-Induced Lupus Erythematosus: Incidence, Management and Prevention

By Chang Christopher

Drug Safety, Vol. 34, Iss. 5, 2011-05 ,pp. : 357-374

Adis International

Access to resources Recommend Favorite

Manage drug-induced parkinsonism through early recognition of the condition and discontinuation of the causative agent

Drugs & Therapy Perspectives, Vol. 28, Iss. 12, 2012-12 ,pp. : 20-23

Adis International

Access to resources Recommend Favorite

Adalimumab/etanercept/infliximab: Drug-induced lupus erythematosus: 3 case reports

Reactions Weekly, Vol. 1, Iss. 1207, 2008-01 ,pp. : 6-7

Adis International

Access to resources Recommend Favorite

Hydralazine: Drug-induced lupus erythematosus and Sweet syndrome: case report

Reactions Weekly, Vol. 1, Iss. 1409, 2012-01 ,pp. : 25-25

Adis International

Access to resources Recommend Favorite

Prevent and manage drug-induced pancreatitis by identifying the offending agent and understanding the underlying mechanisms

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 25, Iss. 8, 2009-08 ,pp. : 19-22

Adis International

Access to resources Recommend Favorite